125 related articles for article (PubMed ID: 36740273)
1. Clinical Complete Response of Recurrent Gastric Cancer after Third-line CPT-11 Chemotherapy.
Hayashi M; Fujita T; Matsushita H
Keio J Med; 2023 Jun; 72(2):60-64. PubMed ID: 36740273
[TBL] [Abstract][Full Text] [Related]
2. Recurrent gastric cancer sustaining a partial response after the nivolumab discontinuation because of immune-related adverse events: a case report.
Arigami T; Matsushita D; Okubo K; Tanaka T; Sasaki K; Noda M; Kita Y; Mori S; Tsuruda Y; Kurahara H; Ohtsuka T
Surg Case Rep; 2020 Oct; 6(1):271. PubMed ID: 33074364
[TBL] [Abstract][Full Text] [Related]
3. Third-line chemotherapy with paclitaxel, irinotecan hydrochloride and cisplatin for recurrent gastric cancer: a case report.
Takahashi N; Suzuki H; Iwabuchi S; Yamazaki Y; Yanaga K
Hepatogastroenterology; 2005; 52(61):326-8. PubMed ID: 15783061
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Long Survival with Hilar Lymph Node Metastasis from Gastric Cancer Successfully Treated with Nivolumab Immunotherapy].
Okada K; Takeoka T; Kobayashi K; Fukunaga M
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2315-2317. PubMed ID: 32156916
[TBL] [Abstract][Full Text] [Related]
5. Nivolumab exerts therapeutic effects against metastatic lesions from early gastric adenocarcinoma with a small proportion of neuroendocrine carcinoma after gastrectomy: a case report.
Sawayama H; Komohara Y; Hirao H; Sakata K; Takata N; Yoshinaka I; Harada K; Baba H
Clin J Gastroenterol; 2020 Oct; 13(5):759-765. PubMed ID: 32592148
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Recurrent Gastric Cancer with Long-Term Control via Two Resections and Multidisciplinary Treatment Including Nivolumab].
Bungo M; Takeno A; Hirao M; Hamakawa T; Yamamoto M; Matsui Y; Tokuyama S; Toshiyama R; Kawai K; Takahashi Y; Sakai K; Doi T; Goto K; Kato T; Takami K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1715-1717. PubMed ID: 38303183
[TBL] [Abstract][Full Text] [Related]
7. [Long-Term Complete Response by CapeOX plus Nivolumab Chemotherapy for Postoperative Recurrence of Gastric Cancer-A Case Report].
Katsuyama S; Masuzawa T; Sugimura K; Yanagisawa K; Shinke G; Kinoshita M; Ikeshima R; Hiraki M; Ohmura Y; Hata T; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2024 Mar; 51(3):326-328. PubMed ID: 38494820
[TBL] [Abstract][Full Text] [Related]
8. [Long-Term Response of Nivolumab for Recurrent Lymph Nodes after Surgery for Gastric Cancer-A Case Report].
Katsuyama S; Takeno A; Masuzawa T; Sugimura K; Kihara Y; Haruna K; Shinke G; Ikeshima R; Kawai K; Hiraki M; Katsura Y; Ohmura Y; Hata T; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1868-1870. PubMed ID: 35045431
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Advanced Gastric Cancer in Which Tumor Relapse Was Observed after Discontinuation of Nivolumab Due to Complete Response, and for Which Re-Administration Was Initiated].
Nishida K; Yagi H; Mizumoto R; Haeno M; Mori S; Nomura M; Yasuyama A; Yoshikawa Y; Sueda T; Matsumura T; Koga C; Miyagaki H; Tei M; Tsujie M; Akamaru Y
Gan To Kagaku Ryoho; 2023 Mar; 50(3):343-345. PubMed ID: 36927904
[TBL] [Abstract][Full Text] [Related]
10. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Kang YK; Chen LT; Ryu MH; Oh DY; Oh SC; Chung HC; Lee KW; Omori T; Shitara K; Sakuramoto S; Chung IJ; Yamaguchi K; Kato K; Sym SJ; Kadowaki S; Tsuji K; Chen JS; Bai LY; Oh SY; Choda Y; Yasui H; Takeuchi K; Hirashima Y; Hagihara S; Boku N
Lancet Oncol; 2022 Feb; 23(2):234-247. PubMed ID: 35030335
[TBL] [Abstract][Full Text] [Related]
11. [A case of gastric cancer showing a durable response after the discontinuation of nivolumab due to the early onset of immune-related adverse events].
Tomita Y; Mori Y; Kanaiwa H; Yamaguchi A; Kitagawa M; Nomura S; Hirano A; Kimura Y; Tsuchida K; Seno K
Nihon Shokakibyo Gakkai Zasshi; 2022; 119(6):551-557. PubMed ID: 35691925
[TBL] [Abstract][Full Text] [Related]
12. [Two Cases of Advanced and Recurrent Gastric Cancer with Long-Term Survival Due to Successful Chemotherapy].
Hasegawa T; Sakuma T; Kinoshita H; Yoshii M; Tamura T; Nakamoto K; Nakagawa Y; Toyokawa T; Tanaka H; Muguruma K; Teraoka H; Hirakawa K; Ohira M
Gan To Kagaku Ryoho; 2021 Jan; 48(1):136-138. PubMed ID: 33468746
[TBL] [Abstract][Full Text] [Related]
13. [Advanced Gastric Cancer with Tumor Shrinkage Persisting after the Discontinuation of Nivolumab-A Case Report].
Sato I; Nakaya N; Obara Y; Ueno S; Nakajima H
Gan To Kagaku Ryoho; 2020 Dec; 47(12):1715-1717. PubMed ID: 33342990
[TBL] [Abstract][Full Text] [Related]
14. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report.
Matsumoto R; Arigami T; Matsushita D; Okubo K; Tanaka T; Yanagita S; Sasaki K; Noda M; Kita Y; Mori S; Kurahara H; Ohtsuka T
World J Surg Oncol; 2020 Jul; 18(1):179. PubMed ID: 32693806
[TBL] [Abstract][Full Text] [Related]
15. [Two Cases of Advanced Gastric Cancer with Para‒Aortic Lymph Node Metastasis or Recurrence for Which Nivolumab Therapy Were Effective].
Kidogami S; Endo S; Tamura S; Murotani M; Shigetsu K; Yoneda N; Imamura H; Mokutani Y; Kishimoto T; Hashimoto Y; Hirose H; Yoshioka S; Sasaki Y
Gan To Kagaku Ryoho; 2021 Apr; 48(4):575-577. PubMed ID: 33976053
[TBL] [Abstract][Full Text] [Related]
16. Successful R0 resection after chemotherapy, including nivolumab, for gastric cancer with liver metastases: three case reports.
Kawai J; Yasufuku I; Fukada M; Asai R; Sato Y; Tajima YJ; Saigo C; Kiyama S; Makiyama A; Tanaka Y; Okumura N; Murase K; Miyazaki T; Matsuhashi N
Surg Case Rep; 2024 Jun; 10(1):138. PubMed ID: 38837046
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness and safety of ramucirumab plus paclitaxel chemotherapy in the treatment of advanced and recurrent gastric cancer.
Kimura M; Usami E; Teramachi H; Yoshimura T
J Oncol Pharm Pract; 2018 Sep; 24(6):403-411. PubMed ID: 28436252
[TBL] [Abstract][Full Text] [Related]
18. [A case of metastatic gastric cancer showing long-term control with nivolumab after pseudoprogression].
Okamoto T; Ueda S
Nihon Shokakibyo Gakkai Zasshi; 2021; 118(6):549-554. PubMed ID: 34108354
[TBL] [Abstract][Full Text] [Related]
19. [A Case of Recurrent Gastric Cancer with Durable Complete Response after Short-Term Nivolumab Therapy].
Yamamichi K; Yamada M; Sumiyama F; Yamamoto N; Hashimoto Y; Satake R; Hatta M; Sakaguchi T; Kotsuka M; Tokuhara K; Inoue K; Sekimoto M
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2052-2054. PubMed ID: 35045490
[TBL] [Abstract][Full Text] [Related]
20. [A case of recurrent gastric cancer successfully treated by a combination of CPT-11 and CDDP as the third-line chemotherapy].
Tonooka T; Yoshioka S; Wakatsuki K; Kataoka M; Miyazawa K; Oeda Y
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2354-6. PubMed ID: 23268075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
